Tri Locum Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108M Buy
424,945
+10,442
+3% +$2.43M 13.27% 1
2026
Q1
$101M Sell
414,503
-188,640
-31% -$43.9M 14.22% 1
2025
Q4
$125M Buy
603,143
+300,312
+99% +$59.4M 16.21% 1
2025
Q3
$56.2M Buy
+302,831
New +$51.9M 12.91% 1
2023
Q3
Sell
-127,362
Closed -$21.1M 71
2023
Q2
$21.1M Buy
+127,362
New +$20.6M 7.83% 2
2021
Q3
Sell
-85,596
Closed -$14.1M 37
2021
Q2
$14.1M Sell
85,596
-83,038
-49% -$13.7M 4.62% 8
2021
Q1
$27.7M Buy
168,634
+6,001
+4% +$971K 6.87% 5
2020
Q4
$25.6M Buy
+162,633
New +$24M 9.3% 1

Other funds holding JNJ

Tri Locum Partners's JNJ Position: Q2 2026 in Review

Tri Locum Partners increased its Johnson & Johnson (JNJ) stake by 2.5% in Q2 2026, buying an estimated $2.43M and bringing the position to 424,945 shares worth $108M. The position accounts for 13.27% of the portfolio, ranked #1.

Tri Locum Partners first reported a position in JNJ in Q4 2020 and has held it in 8 quarters since. The position peaked at $125M in Q4 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Tri Locum Partners held 424,945 shares of Johnson & Johnson worth $108M as of Q2 2026.
  • Tri Locum Partners bought 10,442 Johnson & Johnson shares in Q2 2026, an estimated $2.43M.
  • Johnson & Johnson made up 13.27% of Tri Locum Partners's portfolio in Q2 2026, its #1 holding.
  • Tri Locum Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 8 quarters since.
  • Tri Locum Partners's Johnson & Johnson position peaked at $125M in Q4 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Tri Locum Partners's 13F filing for Q2 2026, filed 14 Aug 2026.